TRIM21 was previously identified as an autoantigen for several autoimmune conditions, including Sjögren syndrome [27], [28], rheumatoid synovitis [29], systemic sclerosis[30], and systemic lupus erythematosus [31]. Here, TRIM21 is linked to systemic sclerosis.